StartUp Health Insights: Sanguine Biosciences Secures $10M | Week of Nov 7, 2023
Capital infusion into Sanguine fast-tracks the development of products critical to cell and gene therapy research and manufacturing.
Sanguine Biosciences, a StartUp Health company on a health moonshot mission to put patients in charge of their health data to accelerate medical research and make precision medicine the standard of care, secured $10M in credit financing from Catalio Capital Management. Sanguine will use the funds to support its recently launched apheresis donation center, develop instrumental cell and gene therapy products derived from apheresis, including GMP-grade and CD34+ mobilized leukopaks, and fund commercial growth. <source>
Other health innovation funding reported this week included:
Gynesonics, a Redwood City, CA-based healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, raised $42.5M led by Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital, with participation from MVM Partners and other healthcare investors. <source>
Engine Biosciences, a Singapore- and Redwood City, CA-based company leveraging machine learning and biology to discover and develop precision oncology medicines, raised $27M led by Polaris Partners, with participation from ClavystBio, Invus, and EDBI, Coronet Ventures, and SEEDS Capital. <source>
Covera Health, a New York, NY-based AI-enabled diagnostic technology company focused on radiology performance measurement and impact, raised $25M led by Insight Partners. <source>
Genome Insight, a San Diego, CA-based precision healthcare solutions company promoting whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease, raised $23M from Samsung Venture Investment Corporation, Asan Foundation, SCL Group, Ignite Innovation, and existing investors. <source>
Free Market Health, a Pittsburgh, PA-based healthtech company focused on the specialty pharmacy ecosystem with a care-driven marketplace platform, raised $20M led by Questa Capital, with participation from Alta Partners, Highmark Ventures, and 653 Investment Partners. <source>
AdaptX, a Seattle, WA-based self-serve clinical management solution company, raised $10M led by Cercano Management, with participation from Memorial Hermann Health System, Morningside Ventures, Founders’ Co-op, Fortson VC, Star Equity, and WRF Capital. <source>
Jona, a personalized healthtech company that uses AI to analyze gut microbiome, raised $5M led by Breyer Capital and Meridian Street Capital. <source>
HeartBeat.bio, a Vienna, Austria-based biotech company providing a human organoid and AI-supported drug discovery platform for heart disease, raised €4.5M ($4.8M) led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures. <source>
Sober Sidekick, a Bentonville, AR-based peer support platform for people who struggle with addiction, raised $2M led by The American Heart Association and Ikigai Growth Partners, with participation from Nina Capital. <source>
ClinOne, a Needham, MA-based provider of a technology platform connecting, informing, and empowering patients in global clinical trials, raised $2M from Boulder Ventures and Highpoint Ventures. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for T1D Innovation
Are you a scientist or innovator focused on T1D innovation who would benefit from education about how to navigate and build a company that will be successful in attracting mission-aligned capital, customers, and collaborators to pursue scientific discoveries in the field of Type 1 diabetes? Learn more and apply for a T1D Fellowship.
Become a Health Moonshot Champion
Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.
Investors: Learn how you can become a Health Moonshot Champion and invest in Health Transformers.
Digital health entrepreneur? Don’t make the journey alone. Learn how Health Transformer University fuels your health moonshot.
Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.